Headlines
-
Battle of the heavyweights
Tuesday | May 13 2025A NEW head-to-head study of tirzepatide (Mounjaro) versus semaglutide (Ozempic/Wegovy) for weight loss in people living with obesity, but not diabetes, has found that Mounjaro resulted in greater weight loss over 72 weeks than Wegovy.
-
TWC celebrates 20 years with OCA
Monday | May 12 2025ON WORLD Ovarian Cancer Day last Thursday, TerryWhite Chemmart (TWC) marked two decades of support for Ovarian Cancer Australia (OCA), reinforcing its commitment to raising awareness and funds for the thousands of Australians affected by ovarian cancer each year.
-
What’s your pall care plan?
Monday | May 12 2025NATIONAL Palliative Care Week (NPCW) runs from 11 to 17 May, with this year's campaign asking Australians "What's your plan.
-
Meet NAPSA directors at PCS25
Monday | May 12 2025THE National Australian Pharmacy Students' Association (NAPSA) is presenting at Pharmacy Careers Summit 2025 (PCS25) on 04 Jul, providing a great opportunity for students to learn about all the ways they can get involved in their peak body and make the most of their student experience.
-
NSW flu vax expansion to kids from 2
Friday | May 9 2025PHARMACISTS in NSW can now administer the flu vaccine to children as young as two, with the NSW Government amending the NSW Pharmacist Vaccination Standards to allow for this expansion of eligibility.
-
PSA leads on pall care meds
Friday | May 9 2025THE Pharmaceutical Society of Australia (PSA) continues to lead on the quality use of medicines as part of a new consortium led by Palliative Care Australia (PCA).
-
AD in over 60s overlooked
Friday | May 9 2025A GLOBAL study of atopic dermatitis (AD) has suggested that the condition has been underestimated as a public health concern among adults over the age of 60.
-
First Nations leadership change
Thursday | May 8 2025THE Pharmaceutical Society of Australia (PSA) has announced the appointment of a new leadership group for the Aboriginal and Torres Strait Islander Pharmacy Practice (ATSIPP) Community of Specialty Interest (CSI), which will be chaired by respected pharmacist and proud Nywaigi Mamu woman, Chastina Heck (pictured).
-
Editor’s Choice: Microshield’s hospital-grade products for home
Thursday | May 8 2025IN partnership with Schulke.
-
Pill testing call after nitazenes found in meds
Thursday | May 8 2025IN THE wake of fresh warnings regarding the presence of the dangerous synthetic opioid nitazene in pharmaceuticals, the Royal Australian College of GPs (RACGP) is calling on state and territory governments to embrace drug testing services to save lives.
